FdaApplication
NDA 020125
Identifiers
- fda_app_no: NDA020125
Properties
| Property | Value |
|---|---|
| applicant_name | PFIZER PHARMACEUTICALS LTD |
| application_type | NDA |
| approval_date | 1999-12-28 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ACCURETIC | HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE | 12.5MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ACCURETIC | HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE | 25MG;EQ 20MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
| ACCURETIC | HYDROCHLOROTHIAZIDE; QUINAPRIL HYDROCHLORIDE | 12.5MG;EQ 10MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL |
3 products